Deep brain stimulation for dystonia

Wei Hu; Matt Stead

doi:10.1186/2047-9158-3-2

Deep brain stimulation for dystonia

Wei Hu, Matt Stead

Neurology

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS.

Original language	English (US)
Article number	2
Journal	Translational Neurodegeneration
Volume	3
Issue number	1
DOIs	https://doi.org/10.1186/2047-9158-3-2
State	Published - Jan 21 2014

Keywords

Deep brain stimulation
Dystonia
Globus pallidus
Neuromodulation
Surgical outcomes

ASJC Scopus subject areas

Clinical Neurology
Cognitive Neuroscience
Cellular and Molecular Neuroscience

Access to Document

10.1186/2047-9158-3-2

Cite this

@article{1eaff6aaa64c47809de9134d95501cac,

title = "Deep brain stimulation for dystonia",

abstract = "Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS.",

keywords = "Deep brain stimulation, Dystonia, Globus pallidus, Neuromodulation, Surgical outcomes",

author = "Wei Hu and Matt Stead",

note = "Funding Information: E.R. and D.G. contributed equally to this chapter. The authors would like to thank their study funders, the APHP (Assistance Publique-H{\^o}pitaux de Paris) and DRRC (Direction R{\'e}gionale de la Recherche Clinique), and are grateful for the support of the patient associations, Alliance France Dystonie and Association des Malades Atteints de Dystonie (AMADYS). The research leading to these results received funding from the program “Investissements d{\textquoteright}Avenir” (ANR-10-IAIHU-06).",

year = "2014",

month = jan,

day = "21",

doi = "10.1186/2047-9158-3-2",

language = "English (US)",

volume = "3",

journal = "Translational Neurodegeneration",

issn = "2047-9158",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Deep brain stimulation for dystonia

AU - Hu, Wei

AU - Stead, Matt

N1 - Funding Information: E.R. and D.G. contributed equally to this chapter. The authors would like to thank their study funders, the APHP (Assistance Publique-Hôpitaux de Paris) and DRRC (Direction Régionale de la Recherche Clinique), and are grateful for the support of the patient associations, Alliance France Dystonie and Association des Malades Atteints de Dystonie (AMADYS). The research leading to these results received funding from the program “Investissements d’Avenir” (ANR-10-IAIHU-06).

PY - 2014/1/21

Y1 - 2014/1/21

N2 - Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS.

AB - Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS.

KW - Deep brain stimulation

KW - Dystonia

KW - Globus pallidus

KW - Neuromodulation

KW - Surgical outcomes

UR - http://www.scopus.com/inward/record.url?scp=84893150805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893150805&partnerID=8YFLogxK

U2 - 10.1186/2047-9158-3-2

DO - 10.1186/2047-9158-3-2

M3 - Review article

AN - SCOPUS:84893150805

SN - 2047-9158

VL - 3

JO - Translational Neurodegeneration

JF - Translational Neurodegeneration

IS - 1

M1 - 2

ER -

Deep brain stimulation for dystonia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this